Track Integra LifeSciences Holdings Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Integra LifeSciences Holdings Corporation IART · Stock Open Integra LifeSciences Holdings Corporation in new tab

14.40 USD
P/E
84.71
EPS
0.17
P/B
1.05
ROE
1.24
Beta
1.28
Target Price
15.67 USD
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
P/E84.71
EPS0.17
Book Value13.71
Price to Book1.05
Debt/Equity187.81
% Insiders14.578%
Growth
Revenue Growth0.02%
Estimates
Forward P/E6.08
Forward EPS2.37
Target Mean Price15.67

DCF valuation

Model fair value for Integra LifeSciences Holdings Corporation (IART)
Result
Sign in to run the valuation for IART.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
9 analysts · consensus Hold · mean target 15.67 USD (low 13.00, high 23.00) · as of 15 Nov 2026
Low 13.00
Mean 15.67
High 23.00
Price 14.40
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Integra LifeSciences Holdings Corporation Logo Integra LifeSciences Holdings Corporation Analysis (IART)

United States Health Care Official Website Stock

Is Integra LifeSciences Holdings Corporation a good investment? Integra LifeSciences Holdings Corporation (IART) is currently trading at 14.40 USD. Market analysts have a consensus price target of 15.67 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 84.71. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Integra LifeSciences Holdings Corporation is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is 2.37.

Investor FAQ

Does Integra LifeSciences Holdings Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of 0.17.

Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Exchange Ticker
NMS (United States) IART
FRA (Germany) IL3.F
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 26, 1998 1:2
July 1, 2015 1.11
Jan. 4, 2017 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion